Search Results - "Comito, T."

Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost by Franceschini, D., Fogliata, A., Spoto, R., Dominici, L., Lo Faro, L., Franzese, C., Comito, T., Lobefalo, F., Reggiori, G., Cozzi, L., Sagona, A., Gentile, D., Scorsetti, M.

“…•Results from an early-stage breast cancer trial with VMAT in hypofractionated SIB.•450 patients were included in the trial with median follow-up of…”
Get full text

Definitive results of a prospective non-randomized phase 2 study on stereotactic body radiation therapy (sbrt) for medically inoperable lung and liver oligometastases from breast cancer by Franceschini, D., Franzese, C., Comito, T., Ilieva, M.B., Spoto, R., Marzo, A.M., Dominici, L., Massaro, M., Bellu, L., Badalamenti, M., Mancosu, P., Scorsetti, M.

“…•Breast cancer patients with visceral oligometastases can be safely and effectively treated with SBRT.•This phase II trial met both coprimary endpoints for…”
Get full text

Oligometastatic Prostate Cancer Treated with Stereotactic Body Radiation Therapy: The Role of Three-Dimensional Tumour Volume in Patient Survival by Franzese, C, Lucchini, R, Roghi, M, Badalamenti, M, Baldaccini, D, Comito, T, Franceschini, D, Navarria, P, Di Cristina, L, Lo Faro, L, Galdieri, C, Reggiori, G, Mancosu, P, Tomatis, S, Scorsetti, M

“…The definition of oligometastatic prostate cancer (OPCa) is currently based solely on the maximum number of detectable metastases, as there are no validated…”
Get full text

Risk-group Classification by Recursive Partitioning Analysis of Patients Affected by Oligometastatic Renal Cancer Treated with Stereotactic Radiotherapy by Franzese, C., Navarria, P., Bellu, L., Marzo, M.A., Clerici, E., Badalamenti, M., Baldaccini, D., Franceschini, D., Comito, T., Teriaca, A., D’agostino, G., Reggiori, G., Tomatis, S., Scorsetti, M.

“…Due to the absence of consensus on metastases-directed treatment in kidney cancer, we conducted an analysis of patients treated with stereotactic radiotherapy…”
Get full text

Clinical results of Stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: a retrospective study by Comito, Tiziana, MD, Cozzi, Luca, PhD, Zerbi, Alessandro, MD, Franzese, Ciro, MD, Clerici, Elena, MD, Tozzi, Angelo, MD, Iftode, Cristina, MD, Navarria, Pierina, MD, D’Agostino, Giuseppe, MD, Fogliata, Antonella, MSc, Mancosu, Pietro, MSc, Tomatis, Stefano, MSc, Carnaghi, Carlo, MD, Personeni, Nicola, MD, Santoro, Armando, MD, Scorsetti, Marta, MD

“…Abstract Objective To evaluate the efficacy and the feasibility of SBRT for selected patients with isolated local recurrence of pancreatic cancer after radical…”
Get full text

Moderate hypofractionated radiotherapy with volumetric modulated arc therapy and simultaneous integrated boost for pelvic irradiation in prostate cancer by Franzese, C., Fogliata, A., D’Agostino, G. R., Di Brina, L., Comito, T., Navarria, P., Cozzi, L., Scorsetti, M.

“…Purpose The optimal treatment for unfavourable intermediate/high-risk prostate cancer is still debated. In the present study, the pattern of toxicity and early…”
Get full text

Role of stereotactic body radiation therapy in the management of oligometastatic pancreatic cancer: single institution experience by Scorsetti, M., Comito, T., Franzese, C., Franceschini, D., De Rose, F., Tomatis, S., D’alessio, A., Prete, M., Bozzarelli, S., Rimassa, L., Personeni, N., Santoro, A.

Get full text

High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low–Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients by D'Agostino, G, Franzese, C, De Rose, F, Franceschini, D, Comito, T, Villa, E, Alongi, F, Liardo, R, Tomatis, S, Navarria, P, Mancosu, P, Reggiori, G, Cozzi, L, Scorsetti, M

“…Abstract Aims The aim of this phase II study was to evaluate the efficacy and toxicity of stereotactic body radiotherapy in patients with low or intermediate…”
Get full text

Outcome Evaluation of Patients With Diagnosed WHO Grade III Glioma Treated According to the Molecular Profile, the Histology, and the Extent of Resection (EOR) by Navarria, P, Pessina, F, Bello, L, Ascolese, A.M, De Rose, F, D'Agostino, G.R, Franzese, C, Comito, T, Bizzi, A, Simonelli, M, Santoro, A, Cozzi, L, Tomatis, S, Scorsetti, M

Get full text

Role of Stereotactic Body Radiation Therapy With Volumetric Modulated Arc Therapy Technique and FFF Beams for Abdomino-Pelvic Lymph Node Metastases in Oligometastatic Patients by Franzese, C, Cozzi, L, Clerici, E, D'Agostino, G.R, Navarria, P, Comito, T, De Rose, F, Ascolese, A.M, Franceschini, D, Mancosu, P, Tomatis, S, Scorsetti, M

Get full text

Is There a Role for Stereotactic Body Radiation Therapy (SBRT) in Oligometastatic Breast Cancer? Results From an Observational Study by De Rose, F, Franceschini, D, Cozzi, L, Comito, T, D'Agostino, G.R, Navarria, P, Ascolese, A.M, Tozzi, A, Iftode, C, Franzese, C, Clerici, E, Tomatis, S, Fogliata, A, Scorsetti, M

Get full text

Radical hypo-fractionated radiotherapy with volumetric modulated arc therapy in lung cancer: A retrospective study of elderly patients with stage III disease by Franceschini, D., De Rose, F., Cozzi, L., Navarria, P., Clerici, E., Franzese, C., Comito, T., Tozzi, A., Iftode, C., D’Agostino, G., Sorsetti, M.

“…Background This study aimed to analyse the feasibility and acute toxicity of radical hypo-fractionated radiotherapy (RT) for elderly patients with…”
Get full text

EP-1279: SABR in inoperable liver oligometastatic patients and radioresistant primary tumors by Clerici, E, Comito, T, Cozzi, L, Fogliata, A, Tozzi, A, Iftode, C, Franzese, C, Navarria, P, D'Agostino, G.R, Mancosu, P, Lobefalo, F, Tomatis, S, Scorsetti, M

Get full text

EP-1168: Phase II trial of hypofractionated VMAT treatment for early stage breast cancer: 2-years outcomes by De Rose, F, Franceschini, D, Fogliata, A, Iftode, C.S, Villa, E, Ascolese, A.M, Navarria, P, Franzese, C, Comito, T, Tozzi, A, Clerici, E, Liardo, R.L.E, Lobefalo, F, D'Agostino, G.R, Scorsetti, M

Get full text

EP-1442: Oligometastatic colorectal cancer in elderly patients: role of stereotactic body radiation therapy by Franceschini, D, Clerici, E, Cozzi, L, Tozzi, A, Iftode, C, Franzese, C, Comito, T, De Rose, F, Navarria, P, D'Agostino, G.R, Villa, E, Rocco Luca, L, Ascolese, A.M, Zucconi, F, Scorsetti, M

Get full text

EP-1472: Role of SBRT with VMAT-FFF for abdomino-pelvic lymph node metastases in oligometastatic patients by Franzese, C, Cozzi, L, Clerici, E, Comito, T, De Rose, F, D'Agostino, G, Tozzi, A, Iftode, C, Ascolese, A, Franceschini, D, Navarria, P, Liardo, L, Paganini, L, Scorsetti, M

Get full text

PV-0511: Hypofractionated VMAT for early stage breast cancer: acute toxicity and cosmesis in 840 patients by Iftode, C, De Rose, F, Franceschini, D, Fogliata, A, Villa, E, Ascolese, A.M, Navarria, P, D'Agostino, G.R, Franzese, C, Comito, T, Tozzi, A, Clerici, E, Liardo, R.L.E, Stravato, A, Scorsetti, M

Get full text

EP-1443: Radical hypofractionated VMAT-RA for stage III NSCLC in the elderly: feasibility and toxicity by Ascolese, A.M, Franceschini, D, De rose, F, Cozzi, L, Navarria, P, Tozzi, A, Iftode, C, Villa, E, Franzese, C, Comito, T, D'agostino, G, Tomatis, S, Liardo, L, Scorsetti, M

Get full text

EP-1053: Toxicity and clinical outcome for patients treated for advanced head and neck cancer with VMAT-SIB by Villa, E, Franzese, C, Fogliata, A, Franceschini, D, D'Agostino, G.R, Clerici, E, Navarria, P, Comito, T, De Rose, F, Iftode, C, Ascolese, A.M, Tozzi, A, Liardo, R.L.E, Mancosu, P, Scorsetti, M

Get full text

EP-1345: SBRT in low- and intermediate-risk prostate cancer: results of a phase II study by D'Agostino, G, Villa, E, Franzese, C, Liardo, R, Reggiori, G, Navarria, P, Iftode, C, De Rose, F, Franceschini, D, Tozzi, A, Comito, T, Ascolese, A, Tomatis, S, Scorsetti, M

Get full text